Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

|

免责声明:本网站目的在于科普相关知识传播,非盈利性质,全部资料均来源于网络,如有侵权请联系删除